Head-to-head comparisons of medication uses, side effects, warnings, and more.
Darzalex (daratumumab) is an anti-CD38 monoclonal antibody. It's used to treat multiple myeloma in adults, often in combination with other anticancer medications. Darzalex (daratumumab) is given as an intravenous infusion through your vein (IV). Typically, you receive it every week or every few weeks, depending on where you are in the treatment process. Some common side effects of Darzalex (daratumumab) include infusion-related reactions, higher risk of infection, and feeling tired.
Sarclisa (isatuximab or isatuximab-irfc) is a monoclonal antibody that’s used to treat a type of blood cancer called multiple myeloma. It helps stop the cancer from growing and spreading. Sarclisa (isatuximab) is given as an intravenous infusion through your vein (IV). It’s typically given together with two other medications to treat cancer. Sarclisa (isatuximab) might cause side effects such as infusion-related reactions, low white blood cell counts, and diarrhea.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.